Xiao Yu

Dr. Xiao Yu

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2023 in Microbial Biotechnology
Verified
Journal Article
Open access
YXYi Xin
Yi Xin
HLHong Lu
Hong Lu
XLXiang Liu
Xiang Liu
JHJunyi He
Junyi He
BLBing Li
Bing Li
XYXiao Yu
Xiao Yu
The human microbiome plays a crucial role in maintaining health, with advances in high‐throughput sequencing technology and reduced sequencing costs triggering a surge in microbiome research. Microbiome studies generally incorporate five key phases: design, sampling, sequencing, analysis, and reporting, with sequencing strategy being a crucial step offering numerous options. Present mainstream sequencing strategies include Amplicon sequencing, Metagenomic Next‐Generation Sequencing (mNGS), and Targeted Next‐Generation Sequencing (tNGS). Two innovative technologies recently emerged, namely MobiMicrobe high‐throughput microbial single‐cell genome sequencing technology and 2bRAD‐M simplified metagenomic sequencing technology, compensate for the limitations of mainstream technologies, each boasting unique core strengths. This paper reviews the basic principles and processes of these three mainstream and two novel microbiological technologies, aiding readers in understanding the benefits and drawbacks of different technologies, thereby guiding the selection of the most suitable method for their research endeavours.

5 November 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
XYXiao Yu
Xiao Yu
TXTao Xiong
Tao Xiong
LYLu Yu
Lu Yu
GLGaisheng Liu
Gaisheng Liu
FYFan Yang
Fan Yang
YSYiwei Shi Yiwei Shi
Yiwei Shi Yiwei Shi
Coal workers’ pneumoconiosis (CWP) is a severe occupational disease resulting from prolonged exposure to coal dust. However, its pathogenesis remains elusive, compounded by a lack of early detection markers and effective treatments. Although the impact of gut microbiota on lung diseases is acknowledged, its specific role in CWP is unclear. This study aims to explore changes in the gut microbiome and metabolome in CWP, while also assessing the correlation between gut microbes and alterations in lung function. Fecal specimens from 43 CWP patients and 48 dust-exposed workers (DEW) were examined using 16S rRNA gene sequencing for microbiota and liquid chromatography-mass spectrometry for metabolite profiling. We observed similar gut microbial α-diversity but significant differences in flora composition (β-diversity) between patients with CWP and the DEW group. After adjusting for age using multifactorial linear regression analysis (MaAsLin2), the distinct gut microbiome profile in CWP patients revealed an increased presence of pro-inflammatory microorganisms such as Klebsiella and Haemophilus . Furthermore, in CWP patients, alterations in gut microbiota—particularly reduced α-diversity and changes in microbial composition—were significantly correlated with impaired pulmonary function, a relationship not observed in DEW. This underscores the specific impact of gut microbiota on pulmonary health in individuals with CWP. Metabolomic analysis of fecal samples from CWP patients and DEW identified 218 differential metabolites between the two groups, with a predominant increase in metabolites in CWP patients, suggesting enhanced metabolic activity in CWP. Key altered metabolites included various lipids, amino acids, and organic compounds, with silibinin emerging as a potential biomarker. Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis linked these metabolites to pathways relevant to the development of pulmonary fibrosis. Additionally, studies on the interaction between microbiota and metabolites showed positive correlations between certain bacteria and increased metabolites in CWP, further elucidating the complex interplay in this disease state. Our findings suggest a potential contributory role of gut microbiota in CWP pathogenesis through metabolic regulation, with implications for diagnostic biomarkers and understanding disease mechanisms, warranting further molecular investigation. IMPORTANCE: The findings have significant implications for the early diagnosis and treatment of coal workers’ pneumoconiosis, highlighting the potential of gut microbiota as diagnostic biomarkers. They pave the way for new research into gut microbiota-based therapeutic strategies, potentially focusing on modifying gut microbiota to mitigate disease progression.

14 October 2015 in Infectious Diseases
Verified
Journal Article
Closed access
PDF file
YSYao Sun
Yao Sun
MLMeimei Li
Meimei Li
LCLijiang Chen
Lijiang Chen
HCHuale Chen
Huale Chen
XYXiao Yu
Xiao Yu
TZTie-li Zhou
Tie-li Zhou
(2016). Prevalence and molecular characterization of carbapenemase-producing gram-negative bacteria from a university hospital in China. Infectious Diseases: Vol. 48, No. 2, pp. 138-146. doi: 10.3109/23744235.2015.1094822

16 March 2024 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
QZQing Zhan
Qing Zhan
GTGaoqin Teng
Gaoqin Teng
WCWeiwei Chen
Weiwei Chen
XYXiao Yu
Xiao Yu
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is a challenging global health threat, resulting in significant morbidity and mortality worldwide. This study aims to determine the molecular characteristics and antimicrobial susceptibility of 263 MRSA isolates in Zhejiang Province, east China. Methods: From 2014 to 2019, a total of 263 MRSA isolates from bloodstream infections (BSIs) were collected from 6 hospitals in 4 cities in Zhejiang province, east China. Antimicrobial susceptibility tests were conducted according to the guidelines set forth by the Clinical and Laboratory Standards Institute (CLSI). To characterize and analyze these isolates, multilocus sequence typing (MLST), staphylococcal cassette chromosome mec (SCCmec) typing, staphylococcal protein A (spa) typing and virulence genes gene profiles were performed. Results: The most predominant clone was ST5-SCCmec II-t311, which accounted for 41.8% (110/263), followed by ST59 (44/263, 16.7%). Compared with non-ST5-II-t311 isolates, ST5-II-t311 isolates were more resistant to erythromycin, tetracycline, levofloxacin, moxifloxacin, and ciprofloxacin, but more susceptible to clindamycin. Moreover, the rates of multidrug resistance were higher in ST5-II-t311 isolates compared to the non-ST5-II-t311 isolates. In comparison to the non-ST5-II-t311 isolates, ST5-II-t311 isolates showed no significant difference in virulence genes detected. Conclusions: MRSA ST5-II-t311 clone has become the most predominant clone in Zhejiang Province, east China and has higher rates of multidrug resistance than other isolates, that should be kept in mind when treating BSI. Moreover, MRSA ST59 clone shows an upward trend and has begun to spread into hospitals. Our findings highlight the importance of epidemiological studies of S. aureus carriage in the eastern region.

17 February 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JZJingfen Zhang
Jingfen Zhang
QLQiaoyu Li
Qiaoyu Li
JLJingjing Liu
Jingjing Liu
FFFangfang Fan
Fangfang Fan
YSYiwei Shi Yiwei Shi
Yiwei Shi Yiwei Shi
XYXiao Yu
Xiao Yu
Objective: A recent alarming report from the World Health Organization highlighted the rapid global spread of a hypervirulent, carbapenem-resistant strain of Klebsiella pneumoniae. The COVID-19 pandemic frequently led to bacterial co-infections, with K. pneumoniae being a common and highly pathogenic agent. This study aimed to assess KP characteristics via whole-genome sequencing and clarify its molecular epidemiology to guide standardized clinical treatment.Methods: Our retrospective analysis of clinical data from COVID-19 patients admitted to our hospital between 7 December 2022, and 2 January 2023-following China’s policies changes, which led to a significant influx of patients-identified 17 K. pneumoniae isolates from sputum samples with bacterial co-infections. These isolates underwent whole-genome sequencing for ST typing, virulence gene annotation, plasmid profiling, and antimicrobial susceptibility testing.Results: Of the 17 K. pneumoniae isolates, 52.9% were hypermucoviscous. Whole genome sequencing identified eight sequence types (STs), with ST23/KL1 being the most prevalent at 35.3%. Virulence genes were present in 94.1% of strains, including Yersiniabactin (70.6%), Aerobactin (82.3%), and Salmochelin (88.2%). Plasmid analysis revealed common IncHI1B/FIBk or IncFIBk types. All isolates were highly sensitive to antibiotics, except for blaSHV resistance. The 17 patients had a median age of 71 years and significant comorbidities, such as hypertension (64.7%) and diabetes (41.2%).Conclusion: The ST types and virulence gene profiles indicate that most K. pneumoniae strains co-infecting COVID-19 patients are common, high-virulence strains prevalent in the Asia-Pacific region. Our findings suggest that COVID-19 may contribute to the spread of hypervirulent K. pneumoniae strains, potentially informing the ongoing WHO epidemic alert.

28 May 2024 in Cancer Gene Therapy
Verified
Journal Article
Closed access
PDF file
CMChao Ma
Chao Ma
YHYuchao Hao
Yuchao Hao
BSBo Shi
Bo Shi
ZWZheng Wu
Zheng Wu
DJDi Jin
Di Jin
BJBilian Jin
Bilian Jin